European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries.

Détails

Ressource 1Télécharger: BIB_C5F7ED687BC3.P001.pdf (684.43 [Ko])
Etat: Public
Version: de l'auteur
ID Serval
serval:BIB_C5F7ED687BC3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries.
Périodique
Journal of Cardiovascular Magnetic Resonance
Auteur(s)
Bruder O., Wagner A., Lombardi M., Schwitter J., van Rossum A., Pilz G., Nothnagel D., Steen H., Petersen S., Nagel E., Prasad S., Schumm J., Greulich S., Cagnolo A., Monney P., Deluigi C.C., Dill T., Frank H., Sabin G., Schneider S., Mahrholdt H.
ISSN
1532-429X (Electronic)
ISSN-L
1097-6647
Statut éditorial
Publié
Date de publication
2013
Volume
15
Numéro
9
Pages
1-9
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't Publication Status: epublish. PDF type: Research
Résumé
BACKGROUND: The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR.
METHODS: Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled.
RESULTS: The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year).
CONCLUSION: The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM.
Pubmed
Web of science
Open Access
Oui
Création de la notice
21/03/2013 17:47
Dernière modification de la notice
20/08/2019 16:41
Données d'usage